Medtronic Acquires SPR Therapeutics
May 20, 2026
Medtronic agreed to acquire SPR Therapeutics for approximately $650 million in cash to add SPR’s FDA-cleared Sprint (SPRINT) temporary peripheral nerve stimulation (PNS) technology to its neuromodulation/pain portfolio. Medtronic later completed the acquisition, integrating the SPRINT PNS System to expand minimally invasive, non-opioid chronic and acute pain treatment options.
- Buyers
- Medtronic plc
- Targets
- SPR Therapeutics, Inc.
- Industry
- Healthcare Services
- Location
- Ohio, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Medtronic to Acquire Scientia Vascular
March 10, 2026
Medical Devices
Medtronic entered into a definitive agreement to acquire Scientia Vascular in a $550 million deal, with customary adjustments and potential earn-out/milestone payments. The acquisition combines Scientia’s neurovascular access devices (guidewires and catheters) with Medtronic’s existing neurovascular therapeutic portfolio to support faster and more reliable treatment for complex stroke cases.
-
Boston Scientific Acquires Valencia Technologies
January 12, 2026
Medical Devices
Boston Scientific acquired Valencia Technologies to advance its urology and pelvic health portfolio, adding Valencia’s implantable tibial nerve stimulation technology. The deal is expected to close in the first half of 2026, with financial terms undisclosed.
-
Merck KGaA Acquires SpringWorks Therapeutics
July 1, 2025
Pharmaceuticals
Merck KGaA, Darmstadt, Germany closed its acquisition of SpringWorks Therapeutics, Inc. in a deal with an enterprise value of $3.4 billion (about €3.0 billion). The acquisition adds SpringWorks’ rare tumor portfolio—including OGSIVEO (nirogacestat) and GOMEKLI (mirdametinib)—to Merck’s Healthcare business and is expected to accelerate growth in rare tumors and expand reach beyond the U.S.
-
Medtronic Acquires Nano Surface Technology Assets from Nanovis
February 12, 2025
Medical Devices
Medtronic plc acquired certain nano surface technology assets and related IP rights from Columbia City, Indiana-based Nanovis to support development of next-generation PEEK interbody fusion devices. Financial terms were not disclosed; the deal transfers Nanovis’ bone-growth nanotechnology (including rights related to Sites Medical’s OsteoSync titanium pads) to Medtronic for integration into its spinal implant portfolio.
-
Boston Scientific Acquires Relievant Medsystems, Inc.
September 19, 2023
Medical Devices
Boston Scientific Corporation agreed to acquire Relievant Medsystems, Inc. to expand its neuromodulation portfolio and add the Intracept intraosseous nerve ablation system for vertebrogenic chronic low back pain. The deal includes an $850 million upfront cash payment plus contingent payments tied to sales, and is expected to close in the first half of 2024; Relievant was projected to generate more than $70 million in sales in 2023.
-
Electromedical Products International Acquires Pulvinar Neuro
March 17, 2022
Medical Devices
Electromedical Products International (EPI) has acquired Pulvinar Neuro, a research-oriented medical device company focused on closed-loop neuromodulation and digital therapeutics. The deal expands EPI's scientific and research capabilities to accelerate development and commercialization of Pulvinar's transcranial alternating current stimulation (tACS), individualized feedback stimulation, and cloud-enabled digital therapeutics.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.